Light Science Technologies Posts Maiden Interim Operating Profit on Strong Margin Growth

However, CEO Simon Deacon candidly notes conversion has been slower than hoped recently. Why? Primarily delays stemming from the Building Safety Regulator getting up to speed and structural changes within the regulator itself, causing a backlog in signing off fire safety for tall buildings.

The good news? Green shoots are appearing. Government initiatives to accelerate social housing remediation and significant provisions set aside by major housebuilders (Barratt Redrow, Bellway, Berkeley, Taylor Wimpey) point to pent-up demand. A major post-period endorsement – confirmation that their Injectaclad system has a 50-year lifespan (over 3x the industry standard) – adds serious credibility and should boost its specification by architects and engineers. The division is primed to scale quickly once the logjam breaks.

2. AgTech (AGT): Patent Power & Global Footprint

AGT revenue grew to £0.5m, maintaining strong margins. Its pipeline is even larger than PFP’s, sitting at over £34m. The strategy focuses on low-risk global expansion via distribution agreements, like the one signed with Agrolux Nederland B.V. This approach is bearing fruit, with the first European orders delivered and a post-period nurturGROW order highlighting its effectiveness.

Key post-period developments solidify AGT’s potential:

• Patent Awarded: For the core air and root zone measurement capabilities of their sensorGROW technology. This protects their innovation and provides a foundation for developing a full environmental sensor suite (including water/air pollution, carbon monitoring).
• Business Development Manager Appointed: Dedicated to driving sensorGROW sales across various AgTech sectors, aiming to boost recurring revenue streams and global reach.

Factors like extreme weather patterns and the global push for sustainable, efficient food production underpin the strong demand outlook for AGT solutions.

3. Contract Electronics Manufacturing (CEM): De-risking & Diversifying

The planned reduction in CEM revenue (down to £3.6m from £4.5m) is part of the strategy. The critical success here is the significant reduction in customer concentration risk within the pest control sector – down to 32.7% of Group revenue (from 55.8% in H1 2024), with a target of 25-30% by year-end.

Management is actively diversifying into higher-margin, more stable markets. The post-period move to join ‘Make UK Defence’ signals a clear intent to capture opportunities in the growing defence sector, aligning with increased UK government spending. The focus is on automation, higher accreditations, and securing larger, long-term contracts with blue-chip clients in sectors like defence and healthcare.

Cash, Costs & The Path Forward

Light Science maintained a solid cash position (£1.1m) and increased available undrawn facilities (£0.7m). Inventory levels stabilised at £0.8m, primarily tied to customer orders. Continued cost control was instrumental in turning the operating profit. Investment continues, notably £0.1m in developing the AGT division’s sensorGROW tech during the period.

The sheer scale of the combined £58m+ quoted sales pipeline (up from £51m YoY) across PFP and AGT is arguably the most exciting takeaway, providing significant visibility on future growth potential.

Outlook: Navigating Delays, Focused on Conversion

The outlook strikes a balanced tone. The acknowledged delays in PFP conversion due to regulatory backlogs are a near-term headwind. However, the Board expresses “optimism that backlogs are now starting to be released” and highlights the division’s £24m pipeline as a powerful lever for future revenue.

AGT is flagged for “significant upside,” bolstered by the sensorGROW patent and distribution deals, with recurring revenue streams expected to build in FY2026. CEM’s diversification journey continues apace.

CEO Simon Deacon’s closing remarks capture the essence: “Having set out its stall to focus on trading at a net profitable level, significant strides have been made… the Board believes that the Group is well-positioned to deliver significant upside to shareholder value.”

The maiden interim operating profit is a tangible milestone. The strategic shift towards high-margin PFP and AGT is demonstrably working. While regulatory delays require monitoring, the sheer weight of the sales pipeline and the foundational progress (patents, accreditations, de-risking) suggest Light Science is building solid momentum for sustainable, profitable growth. One to watch closely as those pipelines start converting.